CTRI/2020/09/027761
Completed
未知
PALLIATIVE CARE NEEDS ASSESSMENT IN ADULT PATIENTS WITH ACUTE LEUKAEMIA: A PROSPECTIVE OBSERVATIONAL STUDY IN A LOW-MIDDLE INCOME COUNTRY SETTING
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: C910- Acute lymphoblastic leukemia [ALL]Health Condition 2: C920- Acute myeloblastic leukemiaHealth Condition 3: C926- Acute myeloid leukemia with 11q23-abnormalityHealth Condition 4: C92A- Acute myeloid leukemia with multilineage dysplasiaHealth Condition 5: C925- Acute myelomonocytic leukemiaHealth Condition 6: C924- Acute promyelocytic leukemia
- Sponsor
- Tata Memorial Hospital
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\)Adult patients of age 18 years or above
- •2\)Newly diagnosed patients with AML/ALL attending the Adult Haemato\- Oncology Joint Clinic at Tata Memorial Hospital and those who have not received any prior cancer directed treatment
- •3\)Planned and expected to receive induction chemotherapy with curative intent
- •4\)Patient has been informed of diagnosis and treatment
- •5\)Able to communicate in English/Marathi/Hindi/Bengali
- •6\)Performance Score of less than or equal to 3 on Eastern Cooperative Oncology Group(ECOG) scale
- •7\)Able to give a written informed consent
Exclusion Criteria
- •1\)Patients who are upfront best supportive care and are planned for treatment with palliative intent
- •2\)Patients with unstable medical conditions , oncological emergencies or psychiatric emergencies.
- •3\)Any form of intellectual disability or cognitive impairment defined as a Mini Mental Status Examination Score less than 24\.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Assessment of supportive care needs in advanced oesophagus cancerCTRI/2020/09/027725Tata Memorial Hospital50
Active, not recruiting
Not Applicable
Curative and palliative treatment of adults aged > 60 years with AML.A randomised trial by OSHO on the role of (1) early intensification {OSHO protocol} vs. common standard arm of German AML Intergroup Study, (2) allografting as consolidative immunotherapy vs. a second consolidation course in elderly patients,(3) prospective evaluation of the decision between curative and palliative treatment-intention. - AML 2004 OSHO #069Acute myelogenous leukemiaEUCTR2005-002833-10-ATGerman Competence network Acute and Chronic Leukemias” sponsored by Federal Ministry of Education a330
Completed
Not Applicable
The symptomatic burden, quality of life in bone and soft tissue cancer patientsCTRI/2020/11/028790All India Institute of Medical SciencesAIIMS178
Completed
Not Applicable
Screening for the Need of Palliative Care among Patients with Advanced, Incurable CancerC00-C80: Malignant neoplasms (excluding malignant hematologic disorders)C00-C97Malignant neoplasmsDRKS00021686niversitätsklinikum Freiburg, Klinik für Palliativmedizin216
Recruiting
Not Applicable
Screening of palliative care needs in patients with incurable hematological malignancies (PallHäm_101)All the above listed diseases needs to be in an incurable stageC81C82C83C84C85C90C91C92Hodgkin lymphomaFollicular lymphomaNon-follicular lymphomaMature T/NK-cell lymphomasOther and unspecified types of non-Hodgkin lymphomaMultiple myeloma and malignant plasma cell neoplasmsLymphoid leukaemiaMyeloid leukaemiaDRKS00017790c/o Sekretariat OSHO500